Surgical Metabolism and Nutrition : eISSN 2465-8383 / pISSN 2233-5765

Table. 1.

Table. 1.

Characteristics of patients included in the study

CharacteristicSarcopenia (n=51)Non-sarcopenia (n=50)P-value
Age63.9 (10.1)63.4 (8.44)0.780
Sex (%)Female18 (35.3%)18 (36%)0.941
Male33 (64.7%)32 (64%)
BMI22.8 (3.1)24.8 (2.69)0.001
PMI515.5 (120.6)742.9 (165.4)0.000
Total bilirubin2.4 (2.0)10.2 (51.1)0.279
AST62.4 (51.8)56.3 (35.4)0.493
ALT73.0 (66.1)56.3 (35.4)0.810
ALP227.6 (123.4)208.3 (151.8)0.485
GGT316.5 (298.5)391.1 (461.2)0.336
Albumin3.7 (0.4)3.7 (0.5)0.679
CA19-9867.5 (2388.1)368.8 (1145.9)0.205
Lymphocyte counts/ratio31.9 (53.1)28.0 (8.1)0.609
Cell differentiation (%)Well8 (17.3%)9 (21.4%)0.726
Moderate30 (65.2%)28 (66.7%)
Poor8 (17.3%)5 (11.9%)
Lymph node metastasis (%)None35 (85.3%)24 (63.1%)0.023
Metastasis6 (14.6%)14 (36.8%)
Surgery (%)PPPD24 (47.0%)30 (60%)0.356
Whipple01 (2%)
BDR11 (21.6%)9 (18%)
ETC16 (31.4%)10 (20%)
Clavian-dindo classification (%)033 (64.8%)30 (60%)0.529
13 (5.9%)3 (6%)
213 (25.5%)12 (24%)
32 (3.9%)2 (4%)
403 (6%)
TNM stage1, 246460.716
3, 443

BMI = Body Mass Index; PMI = Psoas Muscle Index; PPPD = Pylorus Preserving PancreatoDuodenectomy; BDR = Bile Duct Resection.

Surg Metab Nutr 2019;10:54-8 https://doi.org/10.18858/smn.2019.10.2.54
© 2019 Surg Metab Nutr